CACLP 2026 Successfully Concludes in Xiamen, Advancing Innovation and Global Reach in the Field of IVD

The 23rd China International In Vitro Diagnostics by CACLP was successfully held from 21-23 March 2026 in Xiamen, marking another milestone in the event’s continued expansion across China, Southeast Asia and the global market.

CACLP 2026 brought together 1,208 exhibitors across the full IVD value chain and 38,310 professional visitors from over 50 countries and regions. International participation remained a defining highlight, with overseas attendance increasing by 25.9%.

CACLP 2026 Onsite Overview 

CACLP 2026 introduced a more structured exhibition layout, creating a higher-quality environment for business exchange and academic interaction.

New thematic areas included the At-home Testing Pavilion, Medical Research Pavilion, AI Zone and CRO Zone, reflecting evolving market dynamics and highlighted emerging technologies and specialized services. The At-home Testing Pavilion in particular stood out. It brought together over 100 leading companies and showcased a comprehensive ecosystem across four key segments: chronic disease management, respiratory and allergy testing, reproductive health and metabolic nutrition, and smart wearables and daily screening. 

For the first time, noised-controlled halls were implemented to improve the onsite environment, enabling more focused engagement around products, technologies and business discussions.

CACLP 2026 Event Highlights

Beyond the tradeshow, CACLP 2026 hosted the most extensive lineup of concurrent activities ever, integrating academic, clinical and commercial perspectives. 

Flagship conferences include the 13th China IVD Industry Development Conference (CIIDC) and the 11th China Experimental Medicine Conference (CEMC). Both served once again as a premier platform for thought leadership, highlighting key trends shaping laboratory medicine and healthcare. The 1st China AI & Digital Twin Medicine Conference (CAIDM) explored innovative applications in intelligent healthcare, with sessions on smart laboratories, AI agents, and large medical models. Enlightening Lab Med - The 9th IVD Youth Entrepreneur Forum gathered young researchers, clinicians and investors to discuss industry trends and the role of emerging talent. The 8th China IVD Distribution Enterprise Forum explored transformation and innovation within distribution channels. The 6th China Key Raw Material & Parts Forum focused on upstream technological and material innovation. The 2nd National Primary Healthcare Laboratory Forum emphasized strengthening grassroots healthcare systems and advancing integrated medical networks. 

International engagement was further strengthened through the Go Global: China IVD International Forum 2026, which expanded from a half-day program to a one-and-a-half-day agenda. The forum brought together over 10 countries and regions, focusing on Europe, Asia-Pacific and Belt and Road markets, covering regulatory pathways, market access, localization and channel strategies.

The 1st Global IVD Innovation Summit convened 15 distinguished leaders from CAIVD, CPCEM, IFCC, CSLM, KSLM, SACB and AFCC, and academia across Europe, Asia, and Africa to discuss cross-regional collaboration and the future of diagnostics in a data-driven world.

Notably, many of these activities were integrated within exhibition halls, enhancing interaction between academic discussions and industry applications.

CACLP 2026 also augmented its services for international participants, offering comprehensive support including visa assistance, transportation and accommodation guidance, bilingual services, and curated networking programs such as the CACLP International Night, Business Matchmaking, and International Buyer Tour, fostering deeper global engagement. Participation in the International Night exceeded 140 attendees, representing a 40% year-on-year increase.

Digital engagement remained a key component of the event. Although the number of livestream sessions was streamlined, overall viewership increased. Go Global Forum, Deborah’s live, in particular, the three-hour Global IVD Innovation Summit livestream drew over 16,000 views.

With its continued expansion in scale, content, geographic reach and international participation, CACLP 2026 further strengthened its position as a key global platform driving innovation and collaboration across the IVD industry.

CACLP 2027 will return in March 2027. For more information, visit en.caclp.com.

About CACLP

With over 30 years of industry expertise, China International In Vitro Diagnostic Expo by CACLP, is well established as one of the largest exhibitions in the global in vitro diagnostic industry. Each year, it brings together more than 45,000 professionals—including entrepreneurs, scholars, users, and thought leaders from around the world—to exchange insights, foster partnerships, and collectively shape the future of IVD.

The event covers the entire diagnostics value chain from upstream to downstream, offering a comprehensive showcase of products, technologies, and services. Alongside a great number of high-level academic and educational programs held concurrently onsite, and year-round promotional solutions, CACLP continues to serve as a vital platform for global IVD players.

About GL events

Founded in Lyon in 1978, GL events is world-class leading provider of integrated solutions and services for events operating. GL events’ business covers more than 20 countries across five continents, with over 90 branches and more than 6,000 employees. GL events is listed on the Euronext Paris Segment B in 1998.

Through the unique business model – a complementary mix of products and services addressing the needs of all events and customer expectations.

- LIVE: provide comprehensive solutions from design to deliver events, 6,000 events served annually.

- VENUES: provide venues layout and operation, venues management, technical support, and more customized services, more than 60 venues under management.

- EXHIBITIONS: plan and organize tradeshows to bring together B2B & B2C communities, with 480 proprietary exhibitions.